Logo - International Journal of Pharmaceutical Compounding

Hormonal Influences in Prostate Cancer: An Update of a Complex Subject

Author(s):  Biundo Bruce

Issue:  Mar/Apr 2010 - Compounding for Men
View All Articles in Issue

Abstract:  Pharmacists who are involved with patients and physicians have a tremendous opportunity to serve in the realm of prostate cancer, and there are numerous compounding opportunities. For example, compounded testosterone gels can help keep testosterone levels in the mid to upper range with proper dosing and patient counseling. Also, estradiol levels can be held in check or lowered by compounding aromatase- inhibitors such as anastrazole or letrazole into the lower doses that men require, rather than their more potent versions for female patients. Nutraceuticals such as omega-3 fatty acids, vitamin D, zinc, and selenium all play an important role in prostate health, as these agents have 5a-reductase inhibiting and anti-inflammatory properties. More than anything else, we see that the pathophysiology of prostate cancer, although quite complex, is being explored at an amazing rate. The author believes that hormonal balance is critical, and that it is largely hormonal imbalance that is involved in prostate disease. I

Related Keywords: Bruce Biundo, BS, RPh, prostate cancer, estrogens, aromatase inhibitors, androgens, testosterone replacement therapy, hormone nuclear receptors, 5 alpha reductase inhibitors, estradiol, dihydrotestosterone, progesterone, finasteride, dutasteride, estradiol, benign prostatic hypertrophy

Related Categories: CANCER AND AIDS, HRT, NUTRITION AND NUTRICEUTICALS, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE

Purchase this article for download in electronic PDF format from IJPC at for $35 at:
http://www.ijpc.com/Products/ProductAddToCart.cfm?PID=3092

Search the entire IJPC archive by keyword, topic, or issue at:
http://ijpc.com/Products